Endologix Inc. (Nasdaq: ELGX) narrowed fourth quarter losses to 5 cents per share from 11 cents per share a year earlier but the medical device maker forecast 2014 revenue that fell short of expectations sending the stock price plummeting $4.67 to $13.20.
Endologix's Forecast Falls Short
February 28, 2014 at 14:09 PM EST
